[Badali]

That is huge

[energy_wave]

Calcium Carbonate Market Projected to Surpass US$ 76.1 Billion by 2032 With a Sustained CAGR of 5.3%

https://www.globenewswire.com/en/news-release/2023/04/11/2644505/0/en/Calcium-Carbonate-Market-Projected-to-Surpass-US-76-1-Billion-by-2032-With-a-Sustained-CAGR-of-5-3.html

[Badali]

If you have no investment in Bmcs and Usei then why you are worry about others investment. You should focus on your investment wherever you invested . You can invest in Sumcoin and pays 3% fee. Sumcoin created is here to advice everyone.

[Slojab]

I've never seen such denial and unwarranted optimism.

First, having a pile of material, regardless of what it is, is a commodity. There's nothing "bio" about it other than the material is used in the industry. And to ignore the impossibility of just out of the blue being able to acquire $30M worth of material and expect they'll be able to employ people and buy equipment to ship it, is laughable. He had $2077 as of last report! instead, of asking how it's possible, you're just going to go along with Tony's song and dance without questioning any of it.

He can't even keep Current Info yet you believe he's going to spend money on being audited?

If these coins are not valuable then created is failed in his project.

LOLOL If so, Tony is innocent of making a bad investment. Your only focus is to try and diss the developer. Your objectivity is apparent and luckily there are no new suckers to worry about believing anything you say here.

[Badali]

Bmcs is good ticker for future after changed the business plan. Bio is a huge business. We are looking up coming updates. Tony already mentioned in the tweets and PR.
Share structure will be more attractive when holding shares will be retired irrespective of cancelled.
After that with audit financials it will be on QB and QX status.
Who know may be higher exchange when have revenues numbers.
Bmcs is biomed company now.
I will consider Bmcs owned digital assets as Sumcoin.
If these coins are not valuable then created is failed in his project.

[Slojab]

Right on cue. Deny.

There's nothing for me to be desperate about since I'm not in either of Miller's tickers. If you wanted to protect your gamble here, you'd make it a point to confront Tony and make him go on record with the answers to your questions. And if you don't have any questions ...... well that just goes to prove my point that everything negative is to be ignored.

Ostriches don't really bury their heads in the sand, you know. But OTC gamblers do.

[Slojab]

I have no idea what a POW coin is. 🤔

And I doubt we'll ever know what happened to the Sumcoins he had in USEI. I pointed out how he stripped the asset out of USEI without proper compensation and it was met with either a denial or a "so what".

I'm wondering how he'll explain the demise of the pile of calcium.

[Slojab]

Sadly, most here won't think of it as a good discussion. And no one will confront Tony on the points you brought up to see what he says about them. Of course, he won't. That's just not how things work with OTC gambling. Everything negative is to be dismissed without a counter argument or facts.

[energy_wave]

Signs of desperation I see.

[TheStockDok]

You know I just had a thought that should have been obvious.

Tony claimed the coin received for USEI was to remain there in USEI at all times and always maintained that. Then he did some switcharoo with BMCS but maintained it couldn’t be touched.

So the most obvious thing to do is just ask him to show even their POW coin. I bet they can’t show it stayed still.

In fact, I bet if I go find it on the explorer, it will show hundreds if not thousands of transactions. Meaning, he was selling it for his own gain while saying it was an asset. There’s a word for that. It’s called fraud.

[TheStockDok]

Thanks for the reply. Good discussion going here. I’d be interested in being able to talk more in direct messages in fact. Reach out on telegram or Twitter - Sumtoshi

[Slojab]

You should sticky this post. Yours doesn't mean anything. They're just links. And BMCS is no longer Current in the financials, btw.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173345445

[Slojab]

I didn't mean to imply you created the exchange, Ty. Just that whoever created it, it's immaterial to being able to create a market for the coin. I'm waiting to see how he explains what happened to the Sumcoin asset he lists in his financial reports at OTC Markets. If he doesn't have any now and can't show cash from their disposition, I wonder how shareholders will react. No wonder he's gone off in yet another direction. At least, he says he is. I've already raised many points questioning the believability of the calcium nonsense.

Eventually, the house of cards come tumbling down around shareholders. It always does. A long time ago, Tony declared a dividend shares to shareholders but would never issue them. Together with Thomas Cook, he stonewalled everyone until they just resigned themselves that Tony hosed them.

His business model hasn't changed since I've followed him. Amazing someone can make a living this way. I posted this years ago.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=127950205&txt2find=fgft

[TheStockDok]

Actually the exchange wasn’t created by myself or others but is a variation of some kind from opentrade. Looks similar to fiberchange dot com
Anyway, it’s unclear why anyone here even talks about Sumcoin. The company has none of it so saying that they do (on their part) is just a lie. Probably fraud by now.
Learned this week that Tony had his son sell their coin (taken from USEI) and the son sold it to people in Vegas.
Regarding another comment I read here, I also learned that Tony’s business model is this.
1. Sell paper shares to people for cash
2. Give paper shares to people for a story line so he can claim assets like this calcium thing.
3. The people can never convert the paper shares for two reasons. First, no transfer agent will do it. Second, Tony will never sign off on it even if it made it through a transfer agent. So he will always just blame the transfer agent.

In summary. I wanted to return shares given in 2014 for work I did for USEI but Tony convinced me there was a cost. I wanted off the ledger. He bartered to “take my shares off the ledger” in exchange for coin.

He did a convincing enough job with the bs stories that even family and friends bought shares when they saw it on Charlie’s Schwab showing Sumcoin Index fund. It’s nothing we talk about. Everyone got burned and when I have brought it up to Tony he never cared. In fact he last said “none of them ever put a penny in my pocket” and that he “doesn’t make money off the stock”. Well now it’s clear how he does. He sells paper. Paper certs that no one will ever convert. Hence the supply never increases.

Remember on 11/18 I said my crystal ball tells me there’s news Monday. It’s because he tells people things before they happen. 11/20 the Monday, there was news.

Sometime in the future he’s going to claim they retired 154 Million of the 202 million shares. That’s probably one of the near term news headlines. It’s all complete horse sh*t to entice new people or old to by more paper certs.

[Badali]

Good question. Sumcoin created person posted here and you were engaged with him on Usei and Bmcs board. I believe he will give you perfect answer.
I just post the information.

[Slojab]

So, the only exchange Sumcoin can be traded on is an exchange that Sumcoin created?

How does that change anything?

[Badali]

So SUMCOIN is now traceable at own exchange

https://sumexchange.com/referals

[creakyhottie]

You may be right. Original order may have been for 5 shares.

The bid/ask here is manipulated. Just trying to show there is activity/interest. That's why so many days volume is 100 shares.

[Slojab]

A partial fill? 😅

Not enough to move the needle though, I guess.

[creakyhottie]

What is strange is that Free Real Time is reflecting a trade today of an absolutely whopping 4 shares at the bid of .016. Talk about tax selling pressure LOL

Date/Time Price Shares Exch/Mkt
11/27/2023 10:34:01 EST I 0.016 4 OTCBB

[Slojab]

Bid is $.016/$.03 while the sp is at $.035.

That's not good.

[Slojab]

I guess I'll take that as a "no"

Hello? Anyone there?

[Slojab]

Does the link work for anyone? I was hoping to see what was shown. It's either an image of a mine or just a pile of material. And since Miller is quotes as stating they acquired a certain tonnage of material, it would indicate the latter.

Our new business plan is an old school commodities plan where we mine our calcium… put in on a truck and then put it on a ship to send it to the client. This business model has traditional profit margins in excess of 33% per transaction. Follow the hyperlink to see actual images taken from our mine (we will continue to post real-time images in the future here)… https://biotechmedics.co/calcium-reserveslocated on our website commented Miller"

Or is the pile of material located at a mine as these pictures from the website might indicate?

https://biotechmedics.co/calcium-reserves/

[Slojab]

This just goes back to what I posted before. Operating expenses.

Miller has no cash. Equipment needs to be bought or leased. People need to be hired to operate said equipment. Equipment needs fuel. Lots of it.

And that's just the obvious immediate needs of a commodities company.

And I still don't understand why he's insisted on referring to a pile of rocks as a mine.

[creakyhottie]

Lookie Here A pile of rocks
Did he cut and paste a picture from Gaza? LOL

@biotecmedics $BMCS has 2 million metric tons of calcium carbonate in the mine... with our option we can be producing here for over a decade... our focus not digital assets anymore ... an old school commodities BP pic.twitter.com/VsnrkUGEn8

— anthony miller (@anthony88205118) November 20, 2023

[energy_wave]

Looks like a lot of progress has been made. Revenue this year, then OTCQX sometime next year. FOMO will take over soon and the price will rise.

This board is already attracting bottom feeders.

[Badali]

$BMCS is moving forward with major milestones. BMCS has now new business plan in Calcium industry. A few major updates about 15c211 , listing on higher tier OTCXB or higher in 2024, Audit Financials and also BMCS already has tiny share structure but issuing and outstanding shares reduction will start with upcoming revenue.
1. This month (November) management met with several brokers and market-makers to update and repost our company's 15c211.This updated 15c211 will allow BMCS stock to be more accessible to a larger market-maker base and remove the warning from our security.
2. Management is actively moving to become a reporting issuer and elevate to the OTCQB or greater in 2024.
3. We will also seek to reduce the I/O common shares once revenue starts to enhance our share value…
4. This week management did file the BMCS 3Q financial filings and did position the Company's audit-ready financials for an imminent audit.

[Slojab]

Well, in their defense, Miller doesn't give them much to pump.

Everything he says, just leaves dumbfounded looks on people's faces. 😵

[goldbarren58]

Ya'll sorta suck at pumping this pig

[Badali]

BioTech Medics Continues to Execute Its Calcium Business Plans
Monday, 20 November 2023 09:00

WOODLAND HILLS, CA / ACCESSWIRE / November 20, 2023 / BioTech Medics, Inc. (OTC PINK:BMCS) is pleased to announce that the Company continues to build the fundamental substructure that will enhance our ability to raise capital to position the organization in a competitive advantage with its calcium carbonate assets to enhance BMCS as a substantial publicly traded firm in this sector. Our website can be found at www.biotechmedics.co

According to Anthony K. Miller, CEO, "As we previously reported, our business model is in the biotech ecosystem, encompassing calcium, calcium carbonate and related products. This month (November) management met with several brokers and market-makers to update and repost our company's 15c211.This updated 15c211 will allow BMCS stock to be more accessible to a larger market-maker base and remove the warning from our security. This action will add value to current and new shareholders, increase the tradability of our stock and give us greater credibility in the financial community; enhancing our ability to raise working capital. Additionally, management is actively moving to become a reporting issuer and elevate to the OTCQB or greater in 2024. We will also seek to reduce the I/O common shares once revenue starts to enhance our share value… All these activities are necessary so that BMCS can capitalize on its significant opportunities.

This week management did file the BMCS 3Q financial filings and did position the Company's audit-ready financials for an imminent audit. We have solid alliance in the calcium sector, and we are comfortable with marketing our calcium to the larger US marketplace that will include a wide variety of products. Raising money for these opportunities is necessary to liberate all the opportunities before us. We are already entertaining purchase orders, and management will do whatever it can to materialize these opportunities and bring capital forward. Our revenue will begin this year (2023). Management expects that this is a long-term venture (with our own physical assets) lasting more than a decade once fully implemented.

OUR FUTURE: This year management (after over 2 years trying to get our name change through FINRA) decided to abandon the name change and the digital asset business plan. Management decided to take the Company 100% back to its biotech roots and did initiate an agreement with certain asset holders in the Dominican Republic with calcium carbonate resources that boast of 3 billion+ metric ton reserves. On September 28, 202 because of a negotiated agreement BioTech Medics procured 2 million metric tons of very high quality (99.8% pure) calcium carbonate to market to a worldwide marketplace. This calcium carbonate has a base value of $30 million dollars (2 million tons @ $15.00 per ton). As management goes into the sales portals it is common that this same calcium carbonate (request for proposals-RFP) has common requested values in excess of $85.00 per metric ton (in the portals). Further note that this was a significant transaction that management negotiated for the firm since the assets were acquired for 2 million Series A preferred shares of stock. Finally, management did procure (along with this transaction) an option to acquire an additional 48 million metric tons of calcium carbonate at a similar transaction value.

Our new business plan is an old school commodities plan where we mine our calcium… put in on a truck and then put it on a ship to send it to the client. This business model has traditional profit margins in excess of 33% per transaction. Follow the hyperlink to see actual images taken from our mine (we will continue to post real-time images in the future here)… https://biotechmedics.co/calcium-reserveslocated on our website commented Miller"

About Calcium Carbonate: The global calcium carbonate market size was valued at USD 44.7 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2030. Increasing demand for paper from packaging applications and hygiene-related products like tissue paper is a significant growth driver. The U.S. has been a prominent destination for the product considering high demand from industries. Paper is the largest application segment of the market, and the U.S. is among the world's largest paper manufacturers.

Calcium carbonate is also used as organic fertilizer, to produce calcium citrate (citric acid), which is used as a food additive, a preservative, an acidifier, or a flavoring agent. It is used in applications such as cleaning agents, cosmetics, pharmaceuticals, and dietary supplements. As utilized in building material, it helps to manufacture mortar that holds together tiles, rubber products, roofing tiles, concrete slabs and stones and is employed in paints and pigments. Additionally, baking powder, wine, dough, plastics, adhesives sealants and more. It is also used to adjust the pH value of water through the neutralization process. Calcium is a widely utilized commodity with tremendous applications.

About BioTech Medics, Inc: BioTech Medics, Inc is a publicly traded Wyoming company traded on the OTC Markets under the stock symbol BMCS located in Los Angeles California. BioTech Medics Inc. has a long and successful history in the biotech sector. The firm going forward will focus on calcium, silica, carbon credits as its business model. Additionally, the firm still has significant other assets and now calcium assets position BMCS above $70 million dollars (transactions before us can increase or reduce those assets… ultimately all our assets are projected be calcium and silica… as the source of our revenue).

Forward-Looking Statements: This press release contains "forward-looking statements" within the meaning of the safe harbour provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected projects of BioTech Medics, Inc., and related companies. All statements that are included in this Press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements involve known and unknown risks, assumptions, uncertainties, and other factors. Statements made in the future tense, and statements using-words-such as "may, "can," "could," "should," "predict," "aim'" "potential," "continue," "opportunity," "intend " "goal," "estimate," "expect," "expectations," "project," "projections," "plans," "anticipates," "believe," "think," "confident" "scheduled" or similar expressions are intended to identify forward-looking statements. Forward-looking statements are not a guarantee of performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and are beyond our control.

These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. We caution you not to place undue reliance on the forward-looking statements, which speak only as of the date of this report and readers should carefully review this report in its entirety. We disclaim any obligation to update any of these forward-looking statements as a result of new information, future events, or otherwise, except as expressly required by law. Further information on our risk factors is contained in our filings with the OTC Markets and the SEC website. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

CONTACT INFORMATION

INVESTOR RELATIONS
STOCK SYMBOL: (BMCS-OTC)
EMAIL: [e-mail] or [e-mail]
WEBSITE: www.biotechmedics.co
PHONE: [phone].544.0275
LOCATION: WOODLAND HILLS, CA.

https://www.accesswire.com/806938/biotech-medics-continues-to-execute-its-calcium-business-plans

[creakyhottie]

They are "entertaining orders". Did not know Tony could sing and dance.
Or perhaps it is a comedy show.

[creakyhottie]

WOODLAND HILLS, CA / ACCESSWIRE / November 20, 2023 / BioTech Medics, Inc.
BMCS
is pleased to announce that the Company continues to build the fundamental substructure that will enhance our ability to raise capital to position the organization in a competitive advantage with its calcium carbonate assets to enhance BMCS as a substantial publicly traded firm in this sector. Our website can be found at www.biotechmedics.co

According to Anthony K. Miller, CEO, "As we previously reported, our business model is in the biotech ecosystem, encompassing calcium, calcium carbonate and related products. This month (November) management met with several brokers and market-makers to update and repost our company's 15c211.This updated 15c211 will allow BMCS stock to be more accessible to a larger market-maker base and remove the warning from our security. This action will add value to current and new shareholders, increase the tradability of our stock and give us greater credibility in the financial community; enhancing our ability to raise working capital. Additionally, management is actively moving to become a reporting issuer and elevate to the OTCQB or greater in 2024. We will also seek to reduce the I/O common shares once revenue starts to enhance our share value… All these activities are necessary so that BMCS can capitalize on its significant opportunities.

This week management did file the BMCS 3Q financial filings and did position the Company's audit-ready financials for an imminent audit. We have solid alliance in the calcium sector, and we are comfortable with marketing our calcium to the larger US marketplace that will include a wide variety of products. Raising money for these opportunities is necessary to liberate all the opportunities before us. We are already entertaining purchase orders, and management will do whatever it can to materialize these opportunities and bring capital forward. Our revenue will begin this year (2023). Management expects that this is a long-term venture (with our own physical assets) lasting more than a decade once fully implemented.

OUR FUTURE: This year management (after over 2 years trying to get our name change through FINRA) decided to abandon the name change and the digital asset business plan. Management decided to take the Company 100% back to its biotech roots and did initiate an agreement with certain asset holders in the Dominican Republic with calcium carbonate resources that boast of 3 billion+ metric ton reserves. On September 28, 202 because of a negotiated agreement BioTech Medics procured 2 million metric tons of very high quality (99.8% pure) calcium carbonate to market to a worldwide marketplace. This calcium carbonate has a base value of $30 million dollars (2 million tons @ $15.00 per ton). As management goes into the sales portals it is common that this same calcium carbonate (request for proposals-RFP) has common requested values in excess of $85.00 per metric ton (in the portals). Further note that this was a significant transaction that management negotiated for the firm since the assets were acquired for 2 million Series A preferred shares of stock. Finally, management did procure (along with this transaction) an option to acquire an additional 48 million metric tons of calcium carbonate at a similar transaction value.

Our new business plan is an old school commodities plan where we mine our calcium… put in on a truck and then put it on a ship to send it to the client. This business model has traditional profit margins in excess of 33% per transaction. Follow the hyperlink to see actual images taken from our mine (we will continue to post real-time images in the future here)… https://biotechmedics.co/calcium-reserveslocated on our website commented Miller"

About Calcium Carbonate: The global calcium carbonate market size was valued at USD 44.7 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2030. Increasing demand for paper from packaging applications and hygiene-related products like tissue paper is a significant growth driver. The U.S. has been a prominent destination for the product considering high demand from industries. Paper is the largest application segment of the market, and the U.S. is among the world's largest paper manufacturers.

Calcium carbonate is also used as organic fertilizer, to produce calcium citrate (citric acid), which is used as a food additive, a preservative, an acidifier, or a flavoring agent. It is used in applications such as cleaning agents, cosmetics, pharmaceuticals, and dietary supplements. As utilized in building material, it helps to manufacture mortar that holds together tiles, rubber products, roofing tiles, concrete slabs and stones and is employed in paints and pigments. Additionally, baking powder, wine, dough, plastics, adhesives sealants and more. It is also used to adjust the pH value of water through the neutralization process. Calcium is a widely utilized commodity with tremendous applications.

"Finish 2023 Strong With 3 Hot Stock Ideas - Practically Free"
Ready for your shot at the next potential 32%, 39% or 45% gains in today's uncertain market? Go here now because you're about to miss Stock Expert Gianni Di Poce's 3 latest stock ideas... Ones that could shift your entire wealth-building journey with just the click of a button. If you're ready to end 2023 strong with 12 hot stock ideas every single month. ACT FAST.

About BioTech Medics, Inc: BioTech Medics, Inc is a publicly traded Wyoming company traded on the OTC Markets under the stock symbol BMCS located in Los Angeles California. BioTech Medics Inc. has a long and successful history in the biotech sector. The firm going forward will focus on calcium, silica, carbon credits as its business model. Additionally, the firm still has significant other assets and now calcium assets position BMCS above $70 million dollars (transactions before us can increase or reduce those assets… ultimately all our assets are projected be calcium and silica… as the source of our revenue).

Forward-Looking Statements: This press release contains "forward-looking statements" within the meaning of the safe harbour provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected projects of BioTech Medics, Inc., and related companies. All statements that are included in this Press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements involve known and unknown risks, assumptions, uncertainties, and other factors. Statements made in the future tense, and statements using-words-such as "may, "can," "could," "should," "predict," "aim'" "potential," "continue," "opportunity," "intend " "goal," "estimate," "expect," "expectations," "project," "projections," "plans," "anticipates," "believe," "think," "confident" "scheduled" or similar expressions are intended to identify forward-looking statements. Forward-looking statements are not a guarantee of performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and are beyond our control.

These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. We caution you not to place undue reliance on the forward-looking statements, which speak only as of the date of this report and readers should carefully review this report in its entirety. We disclaim any obligation to update any of these forward-looking statements as a result of new information, future events, or otherwise, except as expressly required by law. Further information on our risk factors is contained in our filings with the OTC Markets and the SEC website. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

CONTACT INFORMATION

INVESTOR RELATIONS
STOCK SYMBOL: (BMCS-OTC)
EMAIL: [e-mail] or [e-mail]
WEBSITE: www.biotechmedics.co
PHONE: [phone].544.0275
LOCATION: WOODLAND HILLS, CA.

SOURCE: BioTech Medics Inc.

[Slojab]

So, a guy who has no experience in the business connects with an overseas company that has all this calcium carbonate lying around and arranges the purchase of a mountain of the stuff and because he has no cash, gives the company shares of his OTC company instead. Believers in the Earth being flat are falling for it.

Oh and did they get the raw material or did they get mining rights to extract it?

Our new business plan is an old school commodities plan where we mine our calcium… put in on a truck and then put it on a ship to send it to the client.

Will the laborers and shipping company also get preferred shares for their work?

https://www.otcmarkets.com/stock/BMCS/news/BioTech-Medics-Continues-to-Execute-Its-Calcium-Business-Plans?id=422058

[Badali]

@biotecmedics $BMCS PRESS OUT FOR MONDAY...biotech medics CONTINUES TO EXECUTE ITS CALCIUM BUSINESS PLANS

@biotecmedics $BMCS PRESS OUT FOR MONDAY...biotech medics CONTINUES TO EXECUTE ITS CALCIUM BUSINESS PLANS pic.twitter.com/iZUQ8Zh3kx

— anthony miller (@anthony88205118) November 20, 2023

[Badali]

$BMCS focus on calcium on . Here is some markets trends. Always look the market trends to find out future growth:


Calcium Carbonate Market Trends

This section covers the major market trends shaping the Calcium Carbonate Market according to our research experts:

Paper Sector to Dominate the Market



Calcium carbonate is one of the essential ingredients considered for applications in the paper industry, as it is employed as fillers and for coating purposes. The working qualities of CaCO3, like opacity, brightness, and smoothness, make it an ideal component for the manufacturing of writing, printing, and packaging-grade paper.
It is a mineral filler, which substantially reduces the production cost of paper. As the minerals are easier to be dried than fibers, it also reduces the cost of basic materials. Calcium carbonate is also used in paper coating, as it brings out the brightness and smoothness on the surface of printing paper.
In the present scenario, CaCO3 is dominant over other papermaking filler materials. The main reason behind the preference for calcium carbonate is the demand for brighter and bulkier paper. There are significant advantages to the use of CaCO3 in the alkaline papermaking process.
In the paper industry, calcium carbonate is used as a replacement for kaolin. Since the synthesized precipitated calcium carbonate is brighter and whiter than kaolin, many manufacturers have been using it for paper filling and coating purposes. It offers better opacity, gloss, high brightness, surface finishing, and improves printability.
Calcium carbonate is not only used as a substitute for kaolin but also for wood pulp and additives. In the alkaline papermaking process, calcium carbonate is used in a paper mill as a filler material. Calcium carbonate amounts for 32% of the total share of filler and pigments used in paper production.
Currently, the Asia-Pacific leads the market demand for calcium carbonate in the paper industry, with China being the leading consumer. Increasing demand for paper packaging and tissue products is expected to drive the market in the Asia-Pacific region. According to the Indian Paper Manufacturers Association (IPMA), the Indian paper industry accounts for about 4% of the world’s production of paper. The estimated turnover of the industry is INR 70,000 crore (~USD 8,474.56 million) (domestic market size of INR 80,000 crores (~USD 9,685.21 million)), and its contribution to the exchequer is around INR 5,000 crore (~USD 605.33 million).
The packaging demand is driven by rapid economic upticks and growing food consumption in the region. The tissue demand is driven by population growth and improving hygiene standards.
All the aforementioned factors are expected to boost the demand for calcium carbonate during the forecast period. Source: https://www.mordorintelligence.com/industry-reports/calcium-carbonate-market

[Badali]

$BMCS

Calcium Carbonate Market Size, Share & Trends Analysis Report By Type (GCC, PCC), By Application (Automotive, Building & Construction, Pharmaceutical, Agriculture, Pulp & Paper), By Region, And Segment Forecasts, 2023 - 2030

https://www.grandviewresearch.com/industry-analysis/calcium-carbonate-market/methodology

[TheStockDok]

Some people have a pattern to their speech and writing. Take you for example, these two messages have the same idiolect and style of Tony Miller.

Remember that’s how they found the unibomber?